About Cranbury Pharmaceuticals
We are a wholly owned subsidiary of Tris Pharma Inc., a privately held, innovation-driven biopharmaceutical company that is pioneering differentiated approaches to enhance therapeutic benefit and optimize patient outcomes for patients with attention-deficit/hyperactivity disorder (ADHD), pain, addiction and diseases of the central nervous system (CNS).
We are focused on identifying strategic partners across the world with the requisite capabilities and strengths to develop generic products that differentiate and add value to our portfolios.
Our products are developed and manufactured under strict cGMP/GLP regulations in our state-of-the-art facility in New Jersey, or with partners worldwide.
We have a proven track record of successfully launching products and increasing market share in competitive therapeutic areas.
Our successful business development agreements pair licensing, acquisition, and/or co-development with creative deal structures that benefit both parties.
Cranbury Pharmaceuticals Team
Kevin Walker
Senior VP, Generic Division
Shiphrah Kamble
Director, Sales Operations
Maulik Parikh
Associate Director, Business Development
Kevin Walker Vice President, Generic Sales
Kevin joined Tris Pharma in April 2022 as Vice President, Generic Sales bringing extensive commercial experience to the Generics business unit. Kevin spent his first 12 years developing an expansive background in commercial strategy, account management, marketing, sales operations, and supply chain positions with both smaller and large scale generic pharmaceutical companies. Prior to joining Tris, Kevin worked eight years for Lupin Pharmaceuticals as their National Account Director in their Generics division and over 5 years with Rising Pharmaceuticals and PACK Pharmaceuticals. Kevin earned his BS in Marketing from Northern Illinois University.
Shiphrah Kamble Director, Sales Operations
Shiphrah launched her career with Tris Pharma (Cranbury’s parent company) in 2015. Since that time, she has progressively expanded her expertise in sales, sales operations and analysis, and supply chain. Leveraging her extensive experience in market analysis, complex negotiations, and cross-functional collaboration, Shiphrah ensures that Cranbury and Tris operate effectively as a cohesive team. Shiphrah is a proud alumna of Rutgers University, having earned her BA in Psychology.
Maulik Parikh Business Development Manager
Maulik joined Tris Pharma in 2017 and is responsible for all business development activities. Maulik first joined as sales operations analyst and soon transitioned fully into business development role. Prior to joining Tris, Maulik worked at Dr. Reddy’s Laboratories for 4 years in field sales. He holds an MBA from Silberman College of Business at Fairleigh Dickinson University, NJ and Bachelor of Pharmacy degree from Rajiv Gandhi University, India.
